NDC 72078-0035-02 10
Remifentanil 2 mg Vial [Ultiva] 2024-06-28
| Supplier | Mylan Institutional LLC |
|---|---|
| Availability Status | ASHP Shortage + QS Availability Issues (2024-06-28) |
| Status Description |
QuicksortRx has identified an availability disruption across multiple channels, and ASHP has published an active drug shortage for this product. See their website for more information. |
| Quicksort Status | Availability Issues Detected (2024-06-28) |
| ASHP Status | ASHP Shortage Declared (2024-06-24) |
| QUMI Product Code | wm8tsjr (QuicksortRx Universal Medication Identifier) |
| NDC | Package Count | Supplier | Description | Status | Updated |
|---|---|---|---|---|---|
| 10 | Hikma Pharmaceuticals USA Inc. | Remifentanil 2 mg Vial [Ultiva] | No Availability Issues Detected | ||
| 10 | Fresenius Kabi USA, LLC | Remifentanil 2 mg Vial [Ultiva] | No Availability Issues Detected | ||
| 10 | Mylan Institutional LLC | Remifentanil 2 mg Vial [Ultiva] | No Availability Issues Detected | ||
| 10 | Mylan Institutional LLC | Remifentanil 2 mg Vial [Ultiva] | No Availability Issues Detected |
| Previous Status | Status Start Date | Status End Date |
|---|---|---|
| ASHP Shortage + QS Availability Issues | 2024-06-28 | Current |
| No Availability Issues Detected | 2024-06-28 |
| RXCUI: | 1729584 |
|---|---|
| Dosage Form: | Vial |
| Dosage Route: | INJECTABLE |
| Strength: | 5 |
| Measure: | mg |
| ANDA: | NDA020630 |
| Generic Description: | REMIFENTANIL HCl |
| DEA: | 2 |